COMPANION ANIMAL DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Companion animal include dog, cat, fish, bird, horse, rabbit, hamster, guinea pig, and ferret. Companion animals are used for company, amusement, psychological support, extrovert display and all of the other functions that humans need to share with animals of other species. Increasing adoption of companion animals is expected to propel growth of the global companion animal drugs market over the forecast period. Furthermore, high prevalence of salmonella infection, along with increasing animal healthcare expenditure is also anticipated to assist the market growth during the forecast period.

Key features of the study

• This report provides in-depth analysis of the Global Companion Animal Drugs market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
• It profiles key players in the Global Companion Animal Drugs market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The Global Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Companion Animal Drugs market

Market Segmentation

• By Product Type
  • Antibiotics
  • Anti-inflammatory
  • Parasiticides
  • Ecto-Parasiticides
  • Endo-Parasiticides
  • Heart worm Products
  • Behavioral Products
  • Nutritional Products
  • Skin care Products
  • Vaccines
• By Distribution Channel
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
• Key Players
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Eli Lily & Co.
  • Sanofi (Merial)
  • Ceva Sante Animal
  • Virbac Animal Health
  • Boehringer Ingelheim GmbH